Y-mAbs Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five
Y-mAbs Therapeutics, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $248.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2025-03-04
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $248.00K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $355.00K.
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $355.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $354.70K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2024-12-31 | $248.00K 10-K · filed 2025-03-04 |
| 2023-12-31 | $355.00K 10-K · filed 2024-02-29 |
| 2023-03-31 | $355.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $354.70K 10-K · filed 2023-03-30 |